Zillow Group, Class C Key Executives
This section highlights Zillow Group, Class C's key executives, including their titles and compensation details.
Find Contacts at Zillow Group, Class C
( total contacts)
Zillow Group, Class C Earnings
This section highlights Zillow Group, Class C's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q1 | 2025 | 2025-05-07 | $0.43 | $0.41 |
| Read Transcript | Q4 | 2024 | 2025-02-11 | $0.26 | $0.27 |
| Read Transcript | Q3 | 2024 | 2024-11-06 | $0.29 | $0.35 |
| Read Transcript | Q2 | 2024 | 2024-08-07 | $0.26 | $0.39 |
| Read Transcript | Q1 | 2024 | 2024-05-01 | $0.36 | $0.36 |
| Read Transcript | Q4 | 2023 | 2024-02-13 | $0.12 | $0.20 |
| Read Transcript | Q3 | 2023 | 2023-11-01 | $0.23 | $0.33 |
| Read Transcript | Q2 | 2023 | 2023-08-02 | $0.18 | $0.39 |
| Read Transcript | Q1 | 2023 | 2023-05-03 | $0.12 | $0.35 |
Earnings Reports
Dive into Zillow Group, Class C's earnings with our AI-powered insights.
Financial Statements
Access annual & quarterly financial statements for Zillow Group, Class C, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $2.24B | $1.95B | $1.96B | $8.15B | $3.34B |
| Cost of Revenue | $527.00M | $421.00M | $367.00M | $6.39B | $1.76B |
| Gross Profit | $1.71B | $1.52B | $1.59B | $1.75B | $1.58B |
| Gross Profit Ratio | 76.43% | 78.35% | 81.26% | 21.52% | 47.41% |
| Research and Development Expenses | $585.00M | $560.00M | $498.00M | $474.40M | $518.07M |
| General and Administrative Expenses | $524.00M | $553.00M | $498.00M | $448.77M | $357.12M |
| Selling and Marketing Expenses | $790.00M | $658.00M | $664.00M | $1.08B | $672.82M |
| Selling General and Administrative Expenses | $1.31B | $1.21B | $1.16B | $1.53B | $1.03B |
| Other Expenses | $7.00M | $23.00M | $43.00M | $10.19M | $25.53M |
| Operating Expenses | $1.90B | $1.79B | $1.66B | $2.00B | $1.55B |
| Cost and Expenses | $2.43B | $2.21B | $2.03B | $8.39B | $3.30B |
| Interest Income | $- | $- | $35.00M | $128.00M | $138.00M |
| Interest Expense | $36.00M | $36.00M | $35.00M | $191.91M | $155.23M |
| Depreciation and Amortization | $269.00M | $243.00M | $173.00M | $141.00M | $134.37M |
| EBITDA | $198.00M | $125.00M | $123.00M | $370.00M | $119.96M |
| EBITDA Ratio | 8.86% | 6.43% | 6.28% | 4.54% | 3.59% |
| Operating Income | $-197.00M | $-270.00M | $-26.00M | $-246.21M | $60.94M |
| Operating Income Ratio | -8.81% | -13.88% | -1.33% | -3.02% | 1.82% |
| Total Other Income Expenses Net | $90.00M | $116.00M | $-16.00M | $-138.00M | $-205.05M |
| Income Before Tax | $-107.00M | $-154.00M | $-85.00M | $-526.51M | $-169.64M |
| Income Before Tax Ratio | -4.79% | -7.92% | -4.34% | -6.46% | -5.08% |
| Income Tax Expense | $5.00M | $4.00M | $3.00M | $1.26M | $-7.52M |
| Net Income | $-112.00M | $-158.00M | $-88.00M | $-527.78M | $-162.12M |
| Net Income Ratio | -5.01% | -8.12% | -4.49% | -6.48% | -4.85% |
| EPS | $-0.48 | $-0.68 | $-0.36 | $-2.11 | $-0.72 |
| EPS Diluted | $-0.48 | $-0.68 | $-0.36 | $-2.11 | $-0.72 |
| Weighted Average Shares Outstanding | 234.08M | 233.57M | 242.16M | 249.94M | 223.85M |
| Weighted Average Shares Outstanding Diluted | 234.08M | 233.57M | 242.16M | 249.94M | 223.85M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $598.00M | $554.00M | $581.00M | $572.00M | $529.00M | $474.00M | $496.00M | $506.00M | $469.00M | $435.00M | $483.00M | $1.01B | $4.26B | $3.88B | $1.74B | $1.31B | $1.22B | $788.95M | $656.69M | $768.35M |
| Cost of Revenue | $139.00M | $134.00M | $140.00M | $130.00M | $123.00M | $115.00M | $110.00M | $104.00M | $92.00M | $89.00M | $89.00M | $566.00M | $3.62B | $3.42B | $1.50B | $771.59M | $687.03M | $317.43M | $216.22M | $461.07M |
| Gross Profit | $459.00M | $420.00M | $441.00M | $442.00M | $406.00M | $359.00M | $386.00M | $402.00M | $377.00M | $346.00M | $394.00M | $443.00M | $635.00M | $467.10M | $240.58M | $538.39M | $531.41M | $471.52M | $440.47M | $307.28M |
| Gross Profit Ratio | 76.76% | 75.81% | 75.90% | 77.27% | 76.75% | 75.74% | 77.82% | 79.45% | 80.38% | 79.54% | 81.57% | 43.90% | 14.92% | 12.03% | 13.85% | 41.10% | 43.61% | 59.77% | 67.07% | 39.99% |
| Research and Development Expenses | $149.00M | $149.00M | $145.00M | $144.00M | $147.00M | $141.00M | $142.00M | $140.00M | $137.00M | $129.00M | $142.00M | $119.00M | $114.00M | $114.14M | $111.49M | $128.46M | $148.86M | $127.00M | $127.30M | $128.86M |
| General and Administrative Expenses | $121.00M | $138.00M | $123.00M | $131.00M | $132.00M | $146.00M | $131.00M | $172.00M | $123.00M | $128.00M | $138.00M | $123.00M | $119.00M | $120.09M | $113.13M | $115.10M | $100.55M | $93.43M | $85.89M | $85.51M |
| Selling and Marketing Expenses | $198.00M | $202.00M | $217.00M | $205.00M | $166.00M | $165.00M | $164.00M | $154.00M | $156.00M | $162.00M | $165.00M | $182.00M | $307.00M | $354.49M | $294.35M | $229.43M | $193.59M | $161.74M | $150.83M | $155.60M |
| Selling General and Administrative Expenses | $319.00M | $340.00M | $340.00M | $336.00M | $298.00M | $311.00M | $295.00M | $326.00M | $279.00M | $290.00M | $303.00M | $305.00M | $426.00M | $474.58M | $407.48M | $344.54M | $294.14M | $255.18M | $236.72M | $241.11M |
| Other Expenses | $- | $- | $- | $34.00M | $147.00M | $43.00M | $34.00M | $42.00M | $32.00M | $24.00M | $12.00M | $12.00M | $8.00M | $4.20M | $1.96M | $1.59M | $2.44M | $2.80M | $3.02M | $10.12M |
| Operating Expenses | $468.00M | $489.00M | $486.00M | $480.00M | $445.00M | $452.00M | $437.00M | $466.00M | $416.00M | $419.00M | $445.00M | $424.00M | $540.00M | $588.72M | $518.98M | $473.00M | $443.00M | $382.17M | $364.02M | $369.97M |
| Cost and Expenses | $607.00M | $623.00M | $625.00M | $610.00M | $568.00M | $567.00M | $547.00M | $570.00M | $508.00M | $508.00M | $534.00M | $990.00M | $4.16B | $4.00B | $2.02B | $1.24B | $1.13B | $699.60M | $580.25M | $831.04M |
| Interest Income | $- | $- | $- | $- | $- | $- | $25.00M | $33.00M | $23.00M | $28.00M | $3.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $5.00M | $8.00M | $9.00M | $10.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $44.00M | $68.19M | $44.74M | $39.43M | $39.55M | $40.58M | $39.47M | $37.59M |
| Depreciation and Amortization | $67.00M | $64.00M | $65.00M | $66.00M | $64.00M | $75.00M | $55.00M | $51.00M | $46.00M | $42.00M | $40.00M | $49.00M | $49.00M | $46.75M | $34.95M | $34.53M | $36.25M | $34.03M | $32.41M | $32.44M |
| EBITDA | $80.00M | $26.00M | $-45.00M | $61.00M | $52.00M | $14.00M | $36.00M | $26.00M | $33.00M | $-17.00M | $1.00M | $72.00M | $100.00M | $-144.42M | $80.00M | $96.92M | $110.00M | $121.24M | $111.88M | $-5.08M |
| EBITDA Ratio | 13.38% | 4.69% | -7.75% | 10.66% | 9.83% | 2.95% | 7.26% | 5.14% | 7.04% | -3.91% | 0.21% | 7.14% | 2.35% | -3.72% | 4.61% | 7.40% | 9.03% | 15.37% | 17.04% | -0.66% |
| Operating Income | $-9.00M | $-69.00M | $-45.00M | $-38.00M | $-45.00M | $-105.00M | $-53.00M | $-67.00M | $-7.00M | $-73.00M | $-39.00M | $31.00M | $103.00M | $-195.36M | $-281.63M | $61.73M | $87.59M | $89.35M | $76.45M | $-62.69M |
| Operating Income Ratio | -1.51% | -12.45% | -7.75% | -6.64% | -8.51% | -22.15% | -10.69% | -13.24% | -1.49% | -16.78% | -8.07% | 3.07% | 2.42% | -5.03% | -16.22% | 4.71% | 7.19% | 11.33% | 11.64% | -8.16% |
| Total Other Income Expenses Net | $17.00M | $18.00M | $25.00M | $23.00M | $24.00M | $35.00M | $25.00M | $33.00M | $23.00M | $5.00M | $3.00M | $9.00M | $-20.00M | $-63.99M | $-397.19M | $-38.77M | $-39.93M | $-42.72M | $-36.45M | $-21.08M |
| Income Before Tax | $8.00M | $-51.00M | $-20.00M | $-15.00M | $-21.00M | $-70.00M | $-28.00M | $-34.00M | $-22.00M | $-68.00M | $-48.00M | $14.00M | $7.00M | $-259.35M | $-339.19M | $22.95M | $49.07M | $46.64M | $39.99M | $-83.77M |
| Income Before Tax Ratio | 1.34% | -9.21% | -3.44% | -2.62% | -3.97% | -14.77% | -5.65% | -6.72% | -4.69% | -15.63% | -9.94% | 1.39% | 0.16% | -6.68% | -19.53% | 1.75% | 4.03% | 5.91% | 6.09% | -10.90% |
| Income Tax Expense | $- | $1.00M | $- | $2.00M | $2.00M | $3.00M | $43.00M | $1.00M | $-14.00M | $4.00M | $3.00M | $6.00M | $-9.00M | $1.85M | $-11.01M | $13.31M | $-2.89M | $601.00K | $425.00K | $679.00K |
| Net Income | $8.00M | $-52.00M | $-20.00M | $-17.00M | $-23.00M | $-73.00M | $-28.00M | $-35.00M | $-8.00M | $-72.00M | $-51.00M | $8.00M | $16.00M | $-261.21M | $-328.17M | $9.64M | $51.96M | $46.04M | $39.57M | $-84.45M |
| Net Income Ratio | 1.34% | -9.39% | -3.44% | -2.97% | -4.35% | -15.40% | -5.65% | -6.92% | -1.71% | -16.55% | -10.56% | 0.79% | 0.38% | -6.73% | -18.90% | 0.74% | 4.26% | 5.84% | 6.03% | -10.99% |
| EPS | $0.03 | $-0.22 | $-0.09 | $-0.07 | $-0.10 | $-0.31 | $-0.12 | $-0.15 | $-0.03 | $-0.30 | $-0.21 | $0.03 | $0.06 | $-1.04 | $-1.29 | $0.04 | $0.21 | $0.20 | $0.17 | $-0.38 |
| EPS Diluted | $0.03 | $-0.22 | $-0.09 | $-0.07 | $-0.10 | $-0.31 | $-0.12 | $-0.15 | $-0.03 | $-0.30 | $-0.21 | $0.03 | $0.06 | $-1.03 | $-1.24 | $0.04 | $0.20 | $0.18 | $0.16 | $-0.38 |
| Weighted Average Shares Outstanding | 242.26M | 236.33M | 232.52M | 233.45M | 234.69M | 232.97M | 233.29M | 233.63M | 234.43M | 236.25M | 240.08M | 243.94M | 248.54M | 251.35M | 254.07M | 248.15M | 243.23M | 235.34M | 229.72M | 219.47M |
| Weighted Average Shares Outstanding Diluted | 256.19M | 236.33M | 232.52M | 233.45M | 234.69M | 232.97M | 233.29M | 233.63M | 234.43M | 236.25M | 240.08M | 245.16M | 251.96M | 254.01M | 265.11M | 261.50M | 259.35M | 251.50M | 242.63M | 219.47M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.08B | $1.49B | $1.47B | $2.61B | $1.70B |
| Short Term Investments | $776.00M | $1.32B | $1.90B | $513.92M | $2.22B |
| Cash and Short Term Investments | $1.86B | $2.81B | $3.36B | $3.13B | $3.92B |
| Net Receivables | $104.00M | $96.00M | $72.00M | $77.00M | $69.94M |
| Inventory | $- | $- | $43.00M | $3.91B | $491.29M |
| Other Current Assets | $372.00M | $243.00M | $169.00M | $861.34M | $482.41M |
| Total Current Assets | $2.33B | $3.15B | $3.60B | $7.68B | $4.96B |
| Property Plant Equipment Net | $419.00M | $401.00M | $397.00M | $344.49M | $384.11M |
| Goodwill | $2.82B | $2.82B | $2.37B | $2.37B | $1.98B |
| Intangible Assets | $207.00M | $241.00M | $154.00M | $180.07M | $94.77M |
| Goodwill and Intangible Assets | $3.03B | $3.06B | $2.53B | $2.55B | $2.08B |
| Long Term Investments | $- | $- | $5.00M | $5.00M | $- |
| Tax Assets | $- | $- | $-5.00M | $-5.00M | $- |
| Other Non-Current Assets | $46.00M | $44.00M | $35.00M | $117.12M | $57.89M |
| Total Non-Current Assets | $3.50B | $3.50B | $2.96B | $3.02B | $2.52B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $5.83B | $6.65B | $6.56B | $10.70B | $7.49B |
| Account Payables | $30.00M | $28.00M | $20.00M | $11.00M | $18.97M |
| Short Term Debt | $577.00M | $737.00M | $68.00M | $137.00M | $698.52M |
| Tax Payables | $- | $- | $- | $17.84M | $6.13M |
| Deferred Revenue | $62.00M | $52.00M | $44.00M | $51.48M | $48.99M |
| Other Current Liabilities | $162.00M | $154.00M | $138.00M | $3.67B | $136.02M |
| Total Current Liabilities | $831.00M | $971.00M | $270.00M | $3.88B | $908.64M |
| Long Term Debt | $83.00M | $1.09B | $1.94B | $1.47B | $1.82B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $-14.86M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $14.86M |
| Other Non-Current Liabilities | $67.00M | $60.00M | $-127.00M | $5.00M | $- |
| Total Non-Current Liabilities | $150.00M | $1.16B | $1.81B | $1.47B | $1.84B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $981.00M | $2.13B | $2.08B | $5.35B | $2.74B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $- | $- | $- | $25.00K | $24.00K |
| Retained Earnings | $-1.88B | $-1.77B | $-1.61B | $-1.67B | $-1.14B |
| Accumulated Other Comprehensive Income Loss | $-3.00M | $-5.00M | $-15.00M | $7.23M | $164.00K |
| Other Total Stockholders Equity | $6.73B | $6.30B | $6.11B | $7.00B | $5.88B |
| Total Stockholders Equity | $4.85B | $4.53B | $4.48B | $5.34B | $4.74B |
| Total Equity | $4.85B | $4.53B | $4.48B | $5.34B | $4.74B |
| Total Liabilities and Stockholders Equity | $5.83B | $6.65B | $6.56B | $10.70B | $7.49B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $5.83B | $6.65B | $6.56B | $10.70B | $7.49B |
| Total Investments | $776.00M | $1.32B | $1.90B | $513.92M | $2.22B |
| Total Debt | $660.00M | $1.83B | $1.87B | $5.01B | $2.52B |
| Net Debt | $-422.00M | $340.00M | $401.00M | $2.40B | $816.63M |
Balance Sheet Charts
| Breakdown | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $914.00M | $1.08B | $1.07B | $1.18B | $1.44B | $1.49B | $1.85B | $1.57B | $1.39B | $1.47B | $1.97B | $2.18B | $2.59B | $2.61B | $2.20B | $3.71B | $3.40B | $1.70B | $1.90B | $2.05B |
| Short Term Investments | $689.00M | $776.00M | $1.10B | $1.45B | $1.48B | $1.32B | $1.42B | $1.75B | $1.98B | $1.90B | $1.52B | $1.36B | $1.03B | $513.92M | $1.02B | $880.88M | $1.29B | $2.22B | $1.89B | $1.49B |
| Cash and Short Term Investments | $1.60B | $1.86B | $2.17B | $2.63B | $2.92B | $2.81B | $3.27B | $3.31B | $3.37B | $3.36B | $3.49B | $3.54B | $3.63B | $3.13B | $3.22B | $4.59B | $4.70B | $3.92B | $3.79B | $3.54B |
| Net Receivables | $115.00M | $104.00M | $117.00M | $115.00M | $100.00M | $96.00M | $97.00M | $90.00M | $75.00M | $72.00M | $78.00M | $74.00M | $99.00M | $77.00M | $161.08M | $101.93M | $82.46M | $69.94M | $79.64M | $66.88M |
| Inventory | $- | $- | $- | $-4.00M | $-5.00M | $103.00M | $99.00M | $75.00M | $50.00M | $43.00M | $- | $23.00M | $494.00M | $3.91B | $3.76B | $1.17B | $472.40M | $491.29M | $193.28M | $135.40M |
| Other Current Assets | $436.00M | $372.00M | $379.00M | $386.00M | $305.00M | $243.00M | $248.00M | $230.00M | $202.00M | $169.00M | $204.00M | $204.00M | $571.00M | $605.05M | $696.16M | $420.16M | $502.91M | $482.41M | $243.03M | $165.01M |
| Total Current Assets | $2.15B | $2.33B | $2.67B | $3.13B | $3.32B | $3.15B | $3.61B | $3.63B | $3.65B | $3.60B | $3.77B | $3.84B | $4.79B | $7.68B | $7.83B | $6.29B | $5.75B | $4.96B | $4.31B | $3.90B |
| Property Plant Equipment Net | $94.81M | $103.22M | $417.00M | $419.00M | $409.00M | $401.00M | $427.00M | $417.00M | $404.00M | $397.00M | $388.00M | $379.00M | $374.00M | $344.49M | $361.29M | $365.01M | $370.84M | $384.11M | $392.03M | $395.17M |
| Goodwill | $2.82B | $2.82B | $2.82B | $2.82B | $2.82B | $2.82B | $2.42B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B |
| Intangible Assets | $623.19M | $522.78M | $211.00M | $530.00M | $525.00M | $241.00M | $162.00M | $153.00M | $154.00M | $154.00M | $149.00M | $153.00M | $165.00M | $180.07M | $195.04M | $81.36M | $87.71M | $94.77M | $100.65M | $106.99M |
| Goodwill and Intangible Assets | $3.45B | $3.35B | $3.03B | $3.35B | $3.34B | $3.06B | $2.58B | $2.53B | $2.53B | $2.53B | $2.52B | $2.53B | $2.54B | $2.55B | $2.57B | $2.07B | $2.07B | $2.08B | $2.09B | $2.09B |
| Long Term Investments | $- | $- | $- | $- | $- | $- | $23.00M | $- | $- | $5.00M | $- | $- | $- | $5.00M | $24.90M | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $-23.00M | $- | $- | $-5.00M | $- | $- | $- | $-5.00M | $-24.90M | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $51.00M | $46.00M | $44.00M | $-268.00M | $-250.00M | $44.00M | $39.00M | $43.00M | $36.00M | $35.00M | $36.00M | $33.00M | $117.00M | $112.12M | $50.71M | $58.42M | $58.86M | $57.89M | $59.86M | $58.79M |
| Total Non-Current Assets | $3.59B | $3.50B | $3.49B | $3.50B | $3.50B | $3.50B | $3.04B | $2.99B | $2.97B | $2.96B | $2.95B | $2.94B | $3.03B | $3.02B | $3.01B | $2.49B | $2.50B | $2.52B | $2.54B | $2.55B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $5.75B | $5.83B | $6.16B | $6.63B | $6.82B | $6.65B | $6.66B | $6.62B | $6.61B | $6.56B | $6.72B | $6.78B | $7.82B | $10.70B | $10.84B | $8.78B | $8.26B | $7.49B | $6.84B | $6.45B |
| Account Payables | $35.00M | $30.00M | $53.00M | $39.00M | $34.00M | $28.00M | $28.00M | $21.00M | $21.00M | $20.00M | $19.00M | $16.00M | $24.00M | $17.23M | $30.89M | $15.64M | $17.04M | $18.97M | $19.35M | $14.31M |
| Short Term Debt | $607.00M | $577.00M | $581.00M | $1.22B | $758.00M | $737.00M | $726.00M | $58.00M | $71.00M | $68.00M | $75.00M | $83.00M | $901.00M | $137.00M | $2.70B | $1.35B | $690.64M | $698.52M | $268.29M | $219.46M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $17.84M | $- | $- | $- | $6.13M | $- | $- |
| Deferred Revenue | $70.00M | $62.00M | $57.00M | $59.00M | $58.00M | $52.00M | $48.00M | $49.00M | $49.00M | $44.00M | $50.00M | $52.00M | $56.00M | $51.48M | $54.20M | $53.55M | $54.19M | $48.99M | $49.15M | $44.51M |
| Other Current Liabilities | $163.00M | $162.00M | $163.00M | $157.00M | $151.00M | $154.00M | $139.00M | $205.00M | $146.00M | $138.00M | $168.00M | $153.00M | $221.00M | $3.66B | $321.40M | $231.44M | $171.54M | $136.02M | $129.38M | $109.17M |
| Total Current Liabilities | $875.00M | $831.00M | $854.00M | $1.48B | $1.00B | $971.00M | $941.00M | $333.00M | $287.00M | $270.00M | $312.00M | $304.00M | $1.20B | $3.88B | $3.11B | $1.65B | $933.41M | $908.64M | $466.17M | $387.44M |
| Long Term Debt | $80.00M | $83.00M | $583.00M | $586.00M | $1.09B | $1.09B | $1.18B | $1.92B | $1.93B | $1.94B | $1.94B | $1.81B | $1.81B | $1.47B | $2.12B | $1.47B | $1.80B | $1.82B | $2.05B | $2.03B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-207.72M | $-214.50M | $-214.75M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $14.86M | $21.54M | $14.19M |
| Other Non-Current Liabilities | $37.00M | $67.00M | $66.00M | $63.00M | $64.00M | $60.00M | $10.00M | $-116.00M | $-120.00M | $-127.00M | $-130.00M | $5.00M | $4.00M | $4.47M | $-158.72M | $14.41M | $14.48M | $- | $- | $- |
| Total Non-Current Liabilities | $117.00M | $150.00M | $649.00M | $649.00M | $1.16B | $1.16B | $1.19B | $1.80B | $1.81B | $1.81B | $1.81B | $1.81B | $1.82B | $1.47B | $1.96B | $1.48B | $1.81B | $1.84B | $2.07B | $2.04B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $992.00M | $981.00M | $1.50B | $2.13B | $2.16B | $2.13B | $2.13B | $2.13B | $2.09B | $2.08B | $2.12B | $2.12B | $3.02B | $5.35B | $5.07B | $3.13B | $2.75B | $2.74B | $2.54B | $2.43B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $25.00K | $26.00K | $25.00K | $25.00K | $24.00K | $24.00K | $23.00K |
| Retained Earnings | $-1.87B | $-1.88B | $-1.83B | $-1.81B | $-1.79B | $-1.77B | $-1.70B | $-1.67B | $-1.63B | $-1.61B | $-1.54B | $-1.49B | $-1.50B | $-1.67B | $-1.41B | $-1.08B | $-1.09B | $-1.14B | $-1.19B | $-1.22B |
| Accumulated Other Comprehensive Income Loss | $- | $-3.00M | $4.00M | $-11.00M | $-11.00M | $-5.00M | $-21.00M | $-19.00M | $-3.00M | $-15.00M | $-19.00M | $-13.00M | $-1.00M | $7.23M | $151.00K | $305.00K | $454.00K | $164.00K | $461.00K | $1.52M |
| Other Total Stockholders Equity | $6.63B | $6.73B | $6.48B | $6.32B | $6.47B | $6.30B | $6.25B | $6.17B | $6.16B | $6.11B | $6.15B | $6.17B | $6.30B | $7.00B | $7.18B | $6.72B | $6.60B | $5.88B | $5.49B | $5.25B |
| Total Stockholders Equity | $4.75B | $4.85B | $4.66B | $4.50B | $4.67B | $4.53B | $4.53B | $4.49B | $4.52B | $4.48B | $4.59B | $4.67B | $4.80B | $5.34B | $5.77B | $5.64B | $5.51B | $4.74B | $4.30B | $4.02B |
| Total Equity | $4.75B | $4.85B | $4.66B | $4.50B | $4.67B | $4.53B | $4.53B | $4.49B | $4.52B | $4.48B | $4.59B | $4.67B | $4.80B | $5.34B | $5.77B | $5.64B | $5.51B | $4.74B | $4.30B | $4.02B |
| Total Liabilities and Stockholders Equity | $5.75B | $5.83B | $6.16B | $6.63B | $6.82B | $6.65B | $6.66B | $6.62B | $6.61B | $6.56B | $6.72B | $6.78B | $7.82B | $10.70B | $10.84B | $8.78B | $8.26B | $7.49B | $6.84B | $6.45B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $5.75B | $5.83B | $6.16B | $6.63B | $6.82B | $6.65B | $6.66B | $6.62B | $6.61B | $6.56B | $6.72B | $6.78B | $7.82B | $10.70B | $10.84B | $8.78B | $8.26B | $7.49B | $6.84B | $6.45B |
| Total Investments | $689.00M | $776.00M | $1.10B | $1.45B | $1.48B | $1.32B | $1.42B | $1.75B | $1.98B | $1.90B | $1.52B | $1.36B | $1.03B | $513.92M | $1.02B | $880.88M | $1.29B | $2.22B | $1.89B | $1.49B |
| Total Debt | $687.00M | $660.00M | $1.16B | $1.81B | $1.85B | $1.83B | $1.90B | $1.88B | $1.86B | $1.87B | $1.88B | $1.89B | $2.71B | $5.01B | $4.64B | $2.82B | $2.49B | $2.52B | $2.32B | $2.24B |
| Net Debt | $-227.00M | $-422.00M | $92.00M | $626.00M | $409.00M | $340.00M | $56.00M | $318.00M | $471.00M | $401.00M | $-98.00M | $-291.00M | $119.00M | $2.40B | $2.45B | $-896.89M | $-913.15M | $816.63M | $416.02M | $199.08M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $-112.00M | $-158.00M | $-101.00M | $-527.78M | $-162.12M |
| Depreciation and Amortization | $250.00M | $222.00M | $180.00M | $152.49M | $134.37M |
| Deferred Income Tax | $- | $-20.00M | $- | $-2.75M | $-7.52M |
| Stock Based Compensation | $448.00M | $451.00M | $451.00M | $312.00M | $197.55M |
| Change in Working Capital | $-175.00M | $-165.00M | $3.89B | $-3.75B | $42.91M |
| Accounts Receivables | $-8.00M | $-24.00M | $82.00M | $-82.31M | $-5.58M |
| Inventory | $- | $-127.00M | $3.90B | $-3.83B | $345.28M |
| Accounts Payables | $2.00M | $6.00M | $3.00M | $4.70M | $12.97M |
| Other Working Capital | $-169.00M | $-20.00M | $-98.00M | $150.85M | $-309.76M |
| Other Non Cash Items | $17.00M | $24.00M | $83.00M | $643.13M | $219.01M |
| Net Cash Provided by Operating Activities | $428.00M | $354.00M | $4.50B | $-3.18B | $424.20M |
| Investments in Property Plant and Equipment | $-143.00M | $-135.00M | $-140.00M | $-104.40M | $-108.52M |
| Acquisitions Net | $-7.00M | $-433.00M | $-4.00M | $-497.32M | $23.58M |
| Purchases of Investments | $-706.00M | $-664.00M | $-2.19B | $-516.35M | $-3.28B |
| Sales Maturities of Investments | $1.28B | $1.29B | $802.00M | $2.21B | $2.35B |
| Other Investing Activities | $-28.00M | $-30.00M | $-1.41B | $1.66B | $-23.58M |
| Net Cash Used for Investing Activities | $395.00M | $25.00M | $-1.53B | $1.09B | $-1.04B |
| Debt Repayment | $-1.14B | $- | $-3.44B | $2.78B | $306.77M |
| Common Stock Issued | $- | $- | $- | $545.00M | $411.52M |
| Common Stock Repurchased | $-301.00M | $-424.00M | $-947.00M | $-302.00M | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $- | $72.00M | $46.00M | $127.00M | $444.02M |
| Net Cash Used Provided by Financing Activities | $-1.23B | $-352.00M | $-4.34B | $3.15B | $1.16B |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- |
| Net Change in Cash | $-410.00M | $27.00M | $-1.37B | $1.06B | $548.03M |
| Cash at End of Period | $1.08B | $1.50B | $1.47B | $2.84B | $1.78B |
| Cash at Beginning of Period | $1.50B | $1.47B | $2.84B | $1.78B | $1.23B |
| Operating Cash Flow | $428.00M | $354.00M | $4.50B | $-3.18B | $424.20M |
| Capital Expenditure | $-143.00M | $-165.00M | $-140.00M | $-104.40M | $-108.52M |
| Free Cash Flow | $285.00M | $189.00M | $4.36B | $-3.28B | $315.68M |
Cash Flow Charts
| Breakdown | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $8.00M | $-52.00M | $-20.00M | $-17.00M | $-23.00M | $-73.00M | $-28.00M | $-35.00M | $-22.00M | $-72.00M | $-53.00M | $8.00M | $16.00M | $-261.21M | $-328.17M | $9.64M | $51.96M | $46.04M | $39.57M | $-84.45M |
| Depreciation and Amortization | $67.00M | $64.00M | $56.00M | $66.00M | $64.00M | $70.00M | $55.00M | $51.00M | $46.00M | $42.00M | $40.00M | $49.00M | $49.00M | $46.75M | $34.95M | $34.53M | $36.25M | $34.03M | $32.41M | $32.44M |
| Deferred Income Tax | $- | $- | $- | $- | $- | $9.00M | $-9.00M | $-20.00M | $- | $- | $- | $- | $- | $454.00K | $-3.20M | $2.89M | $-2.89M | $601.00K | $425.00K | $679.00K |
| Stock Based Compensation | $97.00M | $119.00M | $108.00M | $113.00M | $108.00M | $109.00M | $109.00M | $130.00M | $103.00M | $110.00M | $148.00M | $102.00M | $91.00M | $80.21M | $79.41M | $88.39M | $63.67M | $52.45M | $48.96M | $52.35M |
| Change in Working Capital | $-68.00M | $-11.00M | $12.00M | $-106.00M | $-70.00M | $-30.00M | $-60.00M | $-36.00M | $-39.00M | $-11.00M | $23.00M | $690.00M | $3.19B | $-286.33M | $-2.94B | $-570.42M | $47.30M | $-504.75M | $-102.90M | $365.59M |
| Accounts Receivables | $-11.00M | $13.00M | $-2.00M | $-15.00M | $-4.00M | $2.00M | $-7.00M | $-16.00M | $-3.00M | $6.00M | $-5.00M | $25.00M | $56.00M | $6.31M | $-55.81M | $-20.16M | $-12.65M | $8.90M | $-13.00M | $3.85M |
| Inventory | $- | $- | $- | $- | $- | $-19.00M | $-56.00M | $- | $- | $-3.90B | $23.00M | $467.00M | $3.41B | $-256.63M | $-2.89B | $-696.64M | $18.89M | $-297.99M | $-57.88M | $398.55M |
| Accounts Payables | $5.00M | $-23.00M | $14.00M | $5.00M | $6.00M | $-1.00M | $7.00M | $- | $- | $2.00M | $2.00M | $-7.00M | $6.00M | $-13.19M | $15.21M | $4.91M | $-2.23M | $733.00K | $4.74M | $-169.00K |
| Other Working Capital | $-62.00M | $-1.00M | $- | $-96.00M | $-72.00M | $-12.00M | $-4.00M | $-20.00M | $-36.00M | $3.88B | $3.00M | $205.00M | $-287.00M | $-22.81M | $-11.09M | $141.47M | $43.29M | $-216.40M | $-36.76M | $-36.64M |
| Other Non Cash Items | $- | $2.00M | $15.00M | $254.00M | $132.00M | $1.00M | $8.00M | $10.00M | $5.00M | $15.00M | $7.00M | $14.00M | $47.00M | $204.75M | $357.21M | $35.80M | $45.36M | $45.68M | $39.08M | $24.02M |
| Net Cash Provided by Operating Activities | $104.00M | $122.00M | $171.00M | $55.00M | $80.00M | $86.00M | $75.00M | $100.00M | $93.00M | $84.00M | $165.00M | $863.00M | $3.39B | $-215.37M | $-2.80B | $-399.16M | $241.66M | $-325.96M | $57.54M | $390.63M |
| Investments in Property Plant and Equipment | $-36.00M | $-34.00M | $-19.00M | $-44.00M | $-46.00M | $-40.00M | $-41.00M | $-44.00M | $-40.00M | $-36.00M | $-33.00M | $-33.00M | $-38.00M | $-34.65M | $-35.21M | $-18.57M | $-15.97M | $-18.87M | $-23.59M | $-28.59M |
| Acquisitions Net | $- | $-7.00M | $- | $- | $- | $-399.00M | $-34.00M | $9.00M | $9.00M | $-4.00M | $162.00M | $344.00M | $- | $-579.00K | $13.90M | $- | $- | $6.35M | $5.82M | $6.91M |
| Purchases of Investments | $-60.00M | $-38.00M | $-77.00M | $-294.00M | $-297.00M | $-26.00M | $34.00M | $-148.00M | $-490.00M | $-717.00M | $-451.00M | $-498.00M | $-525.00M | $-7.32M | $-509.02M | $- | $- | $-1.41B | $-854.77M | $-957.77M |
| Sales Maturities of Investments | $152.00M | $360.00M | $445.00M | $335.00M | $139.00M | $151.00M | $330.00M | $373.00M | $433.00M | $347.00M | $295.00M | $160.00M | $- | $510.27M | $366.52M | $409.25M | $920.30M | $1.07B | $459.00M | $467.39M |
| Other Investing Activities | $-108.00M | $-7.00M | $-21.00M | $34.00M | $-165.00M | $119.00M | $-34.00M | $-9.00M | $-9.00M | $-378.00M | $-162.00M | $-344.00M | $-530.00M | $496.00M | $-510.64M | $404.00M | $916.00M | $-6.35M | $-5.82M | $-6.91M |
| Net Cash Used for Investing Activities | $-52.00M | $274.00M | $328.00M | $-3.00M | $-204.00M | $-314.00M | $255.00M | $181.00M | $-97.00M | $-410.00M | $-189.00M | $-371.00M | $-563.00M | $467.71M | $-674.44M | $390.67M | $904.33M | $-354.51M | $-419.35M | $-518.98M |
| Debt Repayment | $28.00M | $-502.00M | $-642.00M | $-30.00M | $30.00M | $-54.00M | $25.00M | $24.00M | $5.00M | $-9.00M | $-10.00M | $-752.00M | $-2.67B | $332.05M | $2.13B | $325.66M | $-8.00M | $437.71M | $45.37M | $79.00M |
| Common Stock Issued | $- | $- | $-61.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $21.86M | $- | $545.00M | $411.52M | $- | $411.52M |
| Common Stock Repurchased | $-250.00M | $- | $- | $-292.00M | $-9.00M | $-88.00M | $-100.00M | $-150.00M | $-86.00M | $-174.00M | $-176.00M | $-249.00M | $-348.00M | $-302.30M | $- | $- | $- | $-2.00K | $-2.00K | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $3.00M | $116.00M | $35.00M | $11.00M | $50.00M | $16.00M | $26.00M | $17.00M | $13.00M | $2.00M | $2.00M | $6.00M | $36.00M | $29.67M | $21.39M | $-2.00K | $60.55M | $72.80M | $186.24M | $92.78M |
| Net Cash Used Provided by Financing Activities | $-219.00M | $-386.00M | $-607.00M | $-311.00M | $71.00M | $-126.00M | $-49.00M | $-109.00M | $-68.00M | $-181.00M | $-184.00M | $-995.00M | $-2.98B | $59.42M | $2.15B | $340.19M | $597.55M | $510.51M | $231.60M | $583.30M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $-32.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-167.00M | $10.00M | $-108.00M | $-259.00M | $-53.00M | $-354.00M | $281.00M | $172.00M | $-72.00M | $-507.00M | $-208.00M | $-503.00M | $-152.00M | $311.76M | $-1.33B | $331.70M | $1.74B | $-169.95M | $-130.21M | $454.96M |
| Cash at End of Period | $918.00M | $1.08B | $1.07B | $1.18B | $1.44B | $1.50B | $1.85B | $1.57B | $1.40B | $1.47B | $1.98B | $2.18B | $2.69B | $2.84B | $2.53B | $3.85B | $3.52B | $1.78B | $1.95B | $2.08B |
| Cash at Beginning of Period | $1.08B | $1.07B | $1.18B | $1.44B | $1.50B | $1.85B | $1.57B | $1.40B | $1.47B | $1.98B | $2.18B | $2.69B | $2.84B | $2.53B | $3.85B | $3.52B | $1.78B | $1.95B | $2.08B | $1.62B |
| Operating Cash Flow | $104.00M | $122.00M | $171.00M | $55.00M | $80.00M | $86.00M | $75.00M | $100.00M | $93.00M | $84.00M | $165.00M | $863.00M | $3.39B | $-215.37M | $-2.80B | $-399.16M | $241.66M | $-325.96M | $57.54M | $390.63M |
| Capital Expenditure | $-144.00M | $-41.00M | $-19.00M | $-44.00M | $-46.00M | $-40.00M | $-41.00M | $-44.00M | $-40.00M | $-36.00M | $-33.00M | $-33.00M | $-38.00M | $-34.65M | $-35.21M | $-18.57M | $-15.97M | $-18.87M | $-23.59M | $-28.59M |
| Free Cash Flow | $-40.00M | $81.00M | $152.00M | $11.00M | $34.00M | $46.00M | $34.00M | $56.00M | $53.00M | $48.00M | $132.00M | $830.00M | $3.35B | $-250.02M | $-2.84B | $-417.73M | $225.69M | $-344.83M | $33.95M | $362.04M |
Zillow Group, Inc., a digital real estate company, operates real estate brands on mobile applications and Websites in the United States. The company operates through three segments: Homes; Internet, Media & Technology; and Mortgages. The Homes segment is involved in resale of homes; and title and escrow services to home buyers and sellers, including title search procedures for title insurance policies, escrow, and other closing services. The IMT segment offers premier agent, rentals, and new construction marketplaces, as well as dotloop, display, and other advertising, as well as business software solutions. The Mortgage segment provides home loans; and marketing products including custom quote and connect services. Its portfolio of brands includes Zillow Rentals, Trulia, StreetEasy, Zillow Closing Services, HotPads, and Out East. The company was incorporated in 2004 and is headquartered in Seattle, Washington.
$68.12
Stock Price
$16.39B
Market Cap
6.86K
Employees
Seattle, WA
Location
Revenue (FY 2024)
$2.24B
15.0% YoY
Net Income (FY 2024)
$-112.00M
29.1% YoY
EPS (FY 2024)
$-0.48
29.4% YoY
Free Cash Flow (FY 2024)
$285.00M
50.8% YoY
Profitability
Gross Margin
76.4%
Net Margin
-5.0%
ROE
-2.3%
ROA
-1.9%
Valuation
P/E Ratio
-154.76
P/S Ratio
7.75
EV/EBITDA
85.41
Market Cap
$16.39B
Revenue & Net Income
Profit Margins
Cash Flow Summary
Operating Cash Flow
$428.00M
20.9% YoY
Free Cash Flow
$285.00M
50.8% YoY
Balance Sheet Summary
Total Assets
$5.83B
-12.4% YoY
Total Debt
$660.00M
64.0% YoY
Shareholder Equity
$4.85B
6.9% YoY
Dividend Overview
No Dividend Data
Zillow Group, Inc. Class C doesn't currently pay dividends.
Zillow Group, Class C Dividends
Explore Zillow Group, Class C's dividend history, including dividend yield, payout ratio, and historical payments.
Zillow Group, Class C News
Read the latest news about Zillow Group, Class C, including recent articles, headlines, and updates.
Atossa Therapeutics Announces Full Results from I‑SPY 2 Endocrine‑Optimization Sub‑Study Evaluating Low‑Dose (Z)‑Endoxifen
Feasibility endpoint achieved; rapid Ki‑67 suppression and substantial MRI‑confirmed tumor shrinkage observed with favorable safety profile SEATTLE , May 14, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today reported full results from the Phase 2 Endocrine Optimization Pilot (EOP) sub‑study within the I‑SPY 2 TRIAL evaluating low‑dose oral (Z)‑endoxifen (10 mg daily) as a neoadjuvant treatment in 20 women with stage II/III estrogen‑receptor–positive (ER+), HER2‑negative breast cancer. Key Findings: Primary feasibility goal surpassed – 95 percent of participants (19/20) completed at least 75 percent of planned dosing, far exceeding the predefined 75 percent threshold.
Zillow Group, Inc. (Z) Q1 2025 Earnings Call Transcript
Zillow Group, Inc. (NASDAQ:Z ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Bradley Berning - Investor Relations Jeremy Wacksman - Chief Executive Officer Jeremy Hofmann - Chief Financial Officer Conference Call Participants Ronald Josey - Citigroup Bradley Erickson - RBC Capital Markets John Colantuoni - Jefferies Trevor Young - Barclays Thomas Champion - Piper Sandler Mark Mahaney - Evercore ISI Sergio Segura - KeyBanc Capital Markets Curtis Nagle - Bank of America Merrill Lynch Benjamin Black - Deutsche Bank Research Dae Lee - JPMorgan Maria Ripps - Canaccord Genuity Operator Hello and welcome to Zillow Group's First Quarter 2025 Financial Results Call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for the question-and-answer session.
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio
SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (U.S. Patent No. 12,281,056) directed to highly pure and stable enteric oral formulations comprising (Z)-endoxifen as well as therapeutic methods of using those oral formulations.
Fast-growing Epique Realty to equip agents with Zillow Showcase to win more listings
Brokerage will include Zillow Showcase in its innovative marketing suite to help agents elevate the listing experience for sellers SEATTLE , April 23, 2025 /PRNewswire/ -- Zillow® and Epique Realty today announced a product partnership that gives Epique agents access to Zillow Showcase ℠, an AI-powered listing experience exclusive to Zillow, as part of the brokerage's marketing suite. In offering Zillow Showcase to agents, Epique Realty is enhancing its recruiting and retention efforts by empowering agents to differentiate their brand and listings with innovative, tech-forward solutions.
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio
SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (U.S. Patent No. 12,275,684) directed to enteric oral formulations comprising (Z)-endoxifen as well as methods of treating subjects with those oral formulations.
Zillow Group to Announce First-Quarter 2025 Results May 7
SEATTLE, April 15, 2025 /PRNewswire/ -- Zillow Group, Inc. (Nasdaq: Z and ZG) today announced it will release first-quarter 2025 financial results after market close on Wednesday, May 7, 2025. The company will host a webcast and conference call to discuss its results that afternoon at 2 p.m. PT / 5 p.m. ET.
NextHome joins Zillow in consumer-first commitment to real estate listing transparency
NextHome inks agreement to align with Zillow's listing access standards SEATTLE , April 11, 2025 /PRNewswire/ -- NextHome is the most recent company to join Zillow in its pro-consumer commitment to listing transparency and committing to ensure the largest possible audience of buyers can see its listings. Zillow this week introduced new standards for listing access, which are designed to ensure both consumers and agents have equitable, timely access to real estate information — supporting and protecting a more open and competitive housing market.
Zillow Makes Sneaky Smart Deal with Buffett's Real Estate Business
As Zillow (Z 8.49%) builds out its real estate platform, it needs agents (supply) to come to the market to serve its booming demand. And that's what the company just announced with a new partnership that could make it the aggregator of housing in the U.S.
Zillow product partnership with HomeServices of America empowers agents with Zillow Showcase
Zillow's AI-powered Showcase experience delivers premium listing visibility, helping HomeServices agents attract more buyers and win more listings in a competitive market SEATTLE , April 8, 2025 /PRNewswire/ -- Zillow® and HomeServices of America® are together empowering agents within HomeServices of America companies through the use of Zillow Showcase ℠, an AI-powered listing experience exclusive to Zillow. This collaboration has provided significant advantages to HomeServices of America since its agents began using Zillow Showcase last fall.
Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications
SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, today announced its strategic decision to pursue a metastatic breast cancer indication for (Z)-endoxifen. Atossa believes that pursuing a metastatic indication may offer a more efficient regulatory pathway to deliver (Z)-endoxifen to women in urgent need, and simultaneously plans to work with the FDA to advance additional indications, such as breast cancer prevention and neoadjuvant therapy, that often require larger and longer clinical trials.
Zillow Group, Inc. (Z) Morgan Stanley Technology, Media & Telecom Conference (Transcript)
Zillow Group, Inc. (NASDAQ:Z ) Morgan Stanley Technology, Media & Telecom Conference Call March 5, 2025 1:45 PM ET Company Participants Jeremy Hofmann - Chief Financial Officer Conference Call Participants Brian Nowak - Morgan Stanley Brian Nowak All right. Good morning, everyone.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for Z.